000 01601 a2200421 4500
005 20250517061009.0
264 0 _c20160608
008 201606s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0140975
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSabir, Sarah R
245 0 0 _aLoss of Nek11 Prevents G2/M Arrest and Promotes Cell Death in HCT116 Colorectal Cancer Cells Exposed to Therapeutic DNA Damaging Agents.
_h[electronic resource]
260 _bPloS one
_c2015
300 _ae0140975 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActive Transport, Cell Nucleus
_xgenetics
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCamptothecin
_xanalogs & derivatives
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCell Survival
_xphysiology
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aG2 Phase Cell Cycle Checkpoints
_xdrug effects
650 0 4 _aHCT116 Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIrinotecan
650 0 4 _aM Phase Cell Cycle Checkpoints
_xdrug effects
650 0 4 _aNIMA-Related Kinases
650 0 4 _aProtein Kinases
_xphysiology
650 0 4 _aRNA Interference
700 1 _aSahota, Navdeep K
700 1 _aJones, George D D
700 1 _aFry, Andrew M
773 0 _tPloS one
_gvol. 10
_gno. 10
_gp. e0140975
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0140975
_zAvailable from publisher's website
999 _c25387403
_d25387403